Biotech · Public company · Raleigh, NC, US

Vogenx, Inc.

Ticker VOGX · SEC CIK 0001903784

Track this companyFree. Adds Vogenx, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials31 recruiting or active

Pipeline programs3From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline3

MizagliflozinPhase 2 · Postbariatric HypoglycemiaClinicalTrials.gov · fetched Nov 12, 2026
Mizagliflozin 10 mgPhase 2 · Postbariatric HypoglycemiaClinicalTrials.gov · fetched Nov 12, 2026
Mizagliflozin 5 mgPhase 2 · Postbariatric HypoglycemiaClinicalTrials.gov · fetched Nov 12, 2026

Effect of Mizagliflozin on Hypoglycemia in Patients With Post-Bariatric HypoglycemiaPHASE2 · RECRUITING · started Oct 20, 2026ClinicalTrials.gov NCT07760961 · fetched Nov 12, 2026
Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose ExcursionsPHASE2 · COMPLETED · started Jun 23, 2023ClinicalTrials.gov NCT05721729 · fetched Nov 12, 2026
Effect of Mizagliflozin on Postprandial Glucose and Insulin in Post-Bariatric Hypoglycemia SubjectsPHASE2 · COMPLETED · started Sep 13, 2022ClinicalTrials.gov NCT05541939 · fetched Nov 12, 2026